1,132
Views
2
CrossRef citations to date
0
Altmetric
Research: Original Articles

The additional value of the CRP test in patients in whom the primary care physician excluded pulmonary embolism

, , , , &
Pages 143-149 | Received 30 Jul 2012, Accepted 18 Jan 2013, Published online: 12 Apr 2013

REFERENCES

  • Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000; 83:416–20.
  • Geersing GJ, Erkens PM, Lucassen WA, Buller HR, Cate HT, Hoes AW, et al. Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: Prospective cohort study. Br Med J. 2012;345:e6564.
  • Bernard BS, Bounameaux H, Perneger T, Perrier A. Suspicion of pulmonary embolism in outpatients: Nonspecific chest pain is the most frequent alternative diagnosis. J Intern Med. 2004;256: 153–60.
  • Charles J, Ng A, Britt H. Presentations of shortness of breath in Australian general practice. Aust Fam Physician 2005;34: 520–1.
  • Bosner S, Becker A, Haasenritter J, Abu HM, Keller H, Sonnichsen AC, et al. Chest pain in primary care: Epidemiology and pre-work-up probabilities. Eur J Gen Pract. 2009;15:141–6.
  • Klinkman MS, Stevens D, Gorenflo DW. Episodes of care for chest pain: A preliminary report from MIRNET. Michigan Research Network. J Fam Pract. 1994;38:345–52.
  • Ruigomez A, Rodriguez LA, Wallander MA, Johansson S, Jones R. Chest pain in general practice: Incidence, comorbidity and mortality. Fam Pract. 2006;23:167–74.
  • Querol-Ribelles JM, Tenias JM, Grau E, Querol-Borras JM, Climent JL, Gomez E, et al. Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest 2004;126:1087–92.
  • Castro DJ, Perez-Rodriguez E, Montaner L, Flores J, Nuevo GD. Diagnostic value of D dimer in pulmonary embolism and pneumonia. Respiration 2001;68:371–5.
  • Guneysel O, Pirmit S, Karakurt S. Plasma d-dimer levels increase with the severity of community acquired pneumonia. Tuberk Toraks 2004;52:341–7.
  • Arslan S, Ugurlu S, Bulut G, Akkurt I. The association between plasma D-dimer levels and community-acquired pneumonia. Clinics (Sao Paulo) 2010;65:593–7.
  • Jug B, Vene N, Salobir BG, Sebestjen M, Sabovic M, Keber I. Procoagulant state in heart failure with preserved left ventricular ejection fraction. Int Heart J. 2009;50:591–600.
  • Tokita Y, Kusama Y, Kodani E, Tadera T, Nakagomi A, Atarashi H, et al. Utility of rapid D-dimer measurement for screening of acute cardiovascular disease in the emergency setting. J Cardiol. 2009;53:334–40.
  • Bayes-Genis A, Mateo J, Santalo M, Oliver A, Guindo J, Badimon L, et al. D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J. 2000; 140:379–84.
  • Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med. 1987;317:1361–5.
  • Di Nisio NM, Squizzato A, Rutjes AW, Buller HR, Zwinderman AH, Bossuyt PM. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: A systematic review. J Thromb Haemost. 2007;5:296–304.
  • Righini M, Perrier A, De MP, Bounameaux H. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost. 2008;6:1059–71.
  • Shimony A, Filion KB, Mottillo S, Dourian T, Eisenberg MJ. Meta-analysis of usefulness of D-dimer to diagnose acute aortic dissection. Am J Cardiol. 2011;107:1227–34.
  • Snijders D, Schoorl M, Schoorl M, Bartels PC, van der Werf TS, Boersma WG. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. Eur J Intern Med. 2012;23:436–41.
  • Chalmers JD, Singanayagam A, Scally C, Hill AT. Admission D-dimer can identify low-risk patients with community-acquired pneumonia. Ann Emerg Med. 2009;53:633–8.
  • Cals JW, Schot MJ, de Jong SA, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: A randomized controlled trial. Ann Fam Med. 2010;8:124–33.
  • Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract. 2003;53:358–64.
  • Kass SM, Williams PM, Reamy BV. Pleurisy. Am Fam Physician 2007;75:1357–64.
  • Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388–442.
  • Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/ European Respiratory Society statement: Asthma control and exacerbations: Standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59–99.
  • Janssen KJ, Donders AR, Harrell FE, Jr, Vergouwe Y, Chen Q, Grobbee DE, et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010;63:721–7.
  • Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: A gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087–91.
  • Rubin DB, Schenker N. Multiple imputation in health-care databases: An overview and some applications. Stat Med. 1991; 10:585–98.
  • Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.
  • Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. J Am Med Assoc. 1999;282: 1061–6.
  • Aujesky D, Hayoz D, Yersin B, Perrier A, Barghouth G, Schnyder P, et al. Exclusion of pulmonary embolism using C-reactive protein and D-dimer. A prospective comparison. Thromb Haemost. 2003; 90:1198–203.
  • Steeghs N, Goekoop RJ, Niessen RW, Jonkers GJ, Dik H, Huisman MV. C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism. Br J Haematol. 2005;130:614–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.